436 related articles for article (PubMed ID: 32690473)
1. Neuropsychiatric Impact of Androgen Deprivation Therapy in Patients with Prostate Cancer: Current Evidence and Recommendations for the Clinician.
Siebert AL; Lapping-Carr L; Morgans AK
Eur Urol Focus; 2020 Nov; 6(6):1170-1179. PubMed ID: 32690473
[TBL] [Abstract][Full Text] [Related]
2. Androgen Deprivation Therapy and Mental Health: Impact on Depression and Cognition.
Izard JP; Siemens DR
Eur Urol Focus; 2020 Nov; 6(6):1162-1164. PubMed ID: 31911085
[TBL] [Abstract][Full Text] [Related]
3. Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy.
Tully KH; Nguyen DD; Herzog P; Jin G; Noldus J; Nguyen PL; Kibel AS; Sun M; McGregor B; Basaria S; Trinh QD
Eur Urol Oncol; 2021 Feb; 4(1):66-72. PubMed ID: 31624049
[TBL] [Abstract][Full Text] [Related]
4. Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer.
Gagliano-Jucá T; Travison TG; Nguyen PL; Kantoff PW; Taplin ME; Kibel AS; Manley R; Hally K; Bearup R; Beleva YM; Huang G; Edwards RR; Basaria S
J Pain Symptom Manage; 2018 Feb; 55(2):307-317.e1. PubMed ID: 28941963
[TBL] [Abstract][Full Text] [Related]
5. Androgen deprivation therapy and depression in the prostate cancer patients: review of risk and pharmacological management.
Alwhaibi A; Alsanea S; Almadi B; Al-Sabhan J; Alosaimi FD
Aging Male; 2022 Dec; 25(1):101-124. PubMed ID: 35343371
[No Abstract] [Full Text] [Related]
6. Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners.
Donovan KA; Walker LM; Wassersug RJ; Thompson LM; Robinson JW
Cancer; 2015 Dec; 121(24):4286-99. PubMed ID: 26372364
[TBL] [Abstract][Full Text] [Related]
7. Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.
Zhang Z; Yang L; Xie D; Shi H; Li G; Yu D
Psychooncology; 2017 Dec; 26(12):2238-2244. PubMed ID: 28474429
[TBL] [Abstract][Full Text] [Related]
8. Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.
Donovan KA; Gonzalez BD; Nelson AM; Fishman MN; Zachariah B; Jacobsen PB
Psychooncology; 2018 Jan; 27(1):316-324. PubMed ID: 28557112
[TBL] [Abstract][Full Text] [Related]
9. Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.
Lee M; Jim HS; Fishman M; Zachariah B; Heysek R; Biagioli M; Jacobsen PB
Psychooncology; 2015 Apr; 24(4):472-7. PubMed ID: 24924331
[TBL] [Abstract][Full Text] [Related]
10. Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis.
Nead KT; Sinha S; Nguyen PL
Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):259-264. PubMed ID: 28349979
[TBL] [Abstract][Full Text] [Related]
11. Association of androgen deprivation therapy and depression in the treatment of prostate cancer: A systematic review and meta-analysis.
Nead KT; Sinha S; Yang DD; Nguyen PL
Urol Oncol; 2017 Nov; 35(11):664.e1-664.e9. PubMed ID: 28803700
[TBL] [Abstract][Full Text] [Related]
12. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer.
Taylor LG; Canfield SE; Du XL
Cancer; 2009 Jun; 115(11):2388-99. PubMed ID: 19399748
[TBL] [Abstract][Full Text] [Related]
13. Type of Androgen Deprivation Therapy and Risk of Dementia Among Patients With Prostate Cancer in Taiwan.
Huang WK; Liu CH; Pang ST; Liu JR; Chang JW; Liaw CC; Hsu CL; Lin YC; See LC
JAMA Netw Open; 2020 Aug; 3(8):e2015189. PubMed ID: 32865575
[TBL] [Abstract][Full Text] [Related]
14. Androgen-deprivation therapy, dementia, and cognitive dysfunction in men with prostate cancer: How much smoke and how much fire?
McHugh DJ; Root JC; Nelson CJ; Morris MJ
Cancer; 2018 Apr; 124(7):1326-1334. PubMed ID: 29338083
[TBL] [Abstract][Full Text] [Related]
15. Sexual bother in men with advanced prostate cancer undergoing androgen deprivation therapy.
Benedict C; Traeger L; Dahn JR; Antoni M; Zhou ES; Bustillo N; Penedo FJ
J Sex Med; 2014 Oct; 11(10):2571-80. PubMed ID: 25059094
[TBL] [Abstract][Full Text] [Related]
16. Quantifying observational evidence for risk of dementia following androgen deprivation therapy for prostate cancer: an updated systematic review and meta-analysis.
Cui H; Wang Y; Li F; He G; Jiang Z; Gang X; Wang G
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):15-23. PubMed ID: 32814845
[TBL] [Abstract][Full Text] [Related]
17. Androgen deprivation therapy for prostate cancer and risk of dementia.
Robinson D; Garmo H; Van Hemelrijck M; Damber JE; Bratt O; Holmberg L; Wahlund LO; Stattin P; Adolfsson J
BJU Int; 2019 Jul; 124(1):87-92. PubMed ID: 30637900
[TBL] [Abstract][Full Text] [Related]
18. The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients.
Holtfrerich SKC; Knipper S; Purwins J; Castens J; Beyer B; Schlomm T; Diekhof EK
Psychooncology; 2020 Aug; 29(8):1338-1346. PubMed ID: 32539186
[TBL] [Abstract][Full Text] [Related]
19. Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review.
Alibhai SM; Gogov S; Allibhai Z
Crit Rev Oncol Hematol; 2006 Dec; 60(3):201-15. PubMed ID: 16860998
[TBL] [Abstract][Full Text] [Related]
20. No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer: a 5-year follow-up study.
Kao LT; Lin HC; Chung SD; Huang CY
Asian J Androl; 2017; 19(4):414-417. PubMed ID: 27232853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
